Published in J Pharmacol Exp Ther on November 11, 2009
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia (2014) 1.97
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol (2011) 1.81
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One (2011) 1.69
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav (2013) 1.50
Cannabidiol in humans-the quest for therapeutic targets. Pharmaceuticals (Basel) (2012) 1.02
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. J Biol Chem (2014) 0.97
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol (2013) 0.96
Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Exp Neurol (2011) 0.92
Cannabinoids and Epilepsy. Neurotherapeutics (2015) 0.91
Cannabidivarin is anticonvulsant in mouse and rat. Br J Pharmacol (2012) 0.88
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract (2015) 0.88
The secret "spice": an undetectable toxic cause of seizure. Neurohospitalist (2011) 0.81
Cannabidiol: promise and pitfalls. Epilepsy Curr (2014) 0.81
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice. PeerJ (2016) 0.78
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence. Front Pharmacol (2016) 0.78
Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways. Br J Pharmacol (2011) 0.77
The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signalling. J Physiol (2013) 0.76
Cannabinoids for pediatric epilepsy? Up in smoke or real science? Transl Pediatr (2015) 0.76
Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine. Mediators Inflamm (2015) 0.76
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. PeerJ (2013) 0.75
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. Oncotarget (2016) 0.75
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy. Front Pharmacol (2017) 0.75
Epigenetic control of skin differentiation genes by phytocannabinoids. Br J Pharmacol (2013) 0.75
Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization. J Med Toxicol (2016) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39
The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12
On the cellular and network bases of epileptic seizures. Annu Rev Physiol (2001) 3.27
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol (2007) 3.16
Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci (2000) 2.78
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A (1998) 2.48
Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology (1980) 2.41
Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology (2004) 2.18
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol (2001) 2.15
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol (2005) 2.06
Biological application of microelectrode arrays in drug discovery and basic research. Anal Bioanal Chem (2003) 1.93
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol (2007) 1.85
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem (2009) 1.60
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci (2008) 1.49
The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res (1991) 1.46
Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci (2003) 1.43
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry (2009) 1.40
On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol (2004) 1.39
Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther (1997) 1.36
Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther (2000) 1.34
Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci (2008) 1.32
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol (2001) 1.29
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol (2002) 1.26
MEA-Tools: an open source toolbox for the analysis of multi-electrode data with MATLAB. J Neurosci Methods (2002) 1.23
Two-dimensional monitoring of spiking networks in acute brain slices. Exp Brain Res (2001) 1.19
Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther (2006) 1.15
Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci (2009) 1.12
Cannabidiol: a promising drug for neurodegenerative disorders? CNS Neurosci Ther (2009) 1.12
Hashish. I. The structure of cannabidiol. Tetrahedron (1963) 1.07
Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia (2001) 1.07
Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol (1999) 1.06
Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. J Biol Chem (2008) 1.00
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Phytother Res (2009) 0.98
Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids. Life Sci (1974) 0.97
Development of multi-electrode array screening for anticonvulsants in acute rat brain slices. J Neurosci Methods (2009) 0.96
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Eur J Neurosci (2007) 0.95
Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. Eur J Pharmacol (1982) 0.91
Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor. Mol Pharmacol (2005) 0.91
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function. Pharmacology (2009) 0.90
Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull (1996) 0.90
The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. Br J Pharmacol (2008) 0.89
Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther (1977) 0.89
Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes. Br J Pharmacol (2008) 0.87
A cost-effective high-throughput digital system for observation and acquisition of animal behavioral data. Behav Res Methods (2009) 0.84
Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro. Br J Pharmacol (2009) 0.82
Emerging drugs for epilepsy. Expert Opin Emerg Drugs (2007) 0.80
Decrease in synaptic transmission can reverse the propagation direction of epileptiform activity in hippocampus in vivo. J Neurophysiol (2004) 0.79
Effects of flunarizine on Metrazol-induced seizures in developing rats. Epilepsy Res (1987) 0.78
The effectiveness of web-based interventions designed to decrease alcohol consumption--a systematic review. Prev Med (2008) 2.76
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol (2002) 2.54
Self-esteem and quality of life in obese children and adolescents: a systematic review. Int J Pediatr Obes (2010) 1.88
The feasibility and effectiveness of a web-based personalised feedback and social norms alcohol intervention in UK university students: a randomised control trial. Addict Behav (2008) 1.69
Exploratory randomised controlled trial of a mindfulness-based weight loss intervention for women. Appetite (2008) 1.68
Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther (2011) 1.45
Obesity and risk of low self-esteem: a statewide survey of Australian children. Pediatrics (2006) 1.37
Providing web-based feedback and social norms information to reduce student alcohol intake: a multisite investigation. J Med Internet Res (2010) 1.34
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. Mol Pharmacol (2012) 1.26
Long-term dietary compensation for added sugar: effects of supplementary sucrose drinks over a 4-week period. Br J Nutr (2007) 1.16
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) (2002) 1.15
Recruitment challenges and recommendations for adolescent obesity trials. J Paediatr Child Health (2012) 1.14
Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr (2009) 1.09
Children's residential weight-loss programs can work: a prospective cohort study of short-term outcomes for overweight and obese children. Pediatrics (2005) 1.07
Twelve-month outcomes of the loozit randomized controlled trial: a community-based healthy lifestyle program for overweight and obese adolescents. Arch Pediatr Adolesc Med (2012) 1.05
Changes in undergraduate student alcohol consumption as they progress through university. BMC Public Health (2008) 1.04
Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Exp Neurol (2009) 1.04
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol (2012) 1.03
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure (2012) 1.01
The impact of flavonoids on spatial memory in rodents: from behaviour to underlying hippocampal mechanisms. Genes Nutr (2009) 0.99
Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiol Behav (2011) 0.99
Presynaptic internal Ca2+ stores contribute to inhibitory neurotransmitter release onto mouse cerebellar Purkinje cells. Br J Pharmacol (2002) 0.97
The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur J Neurosci (2007) 0.96
Development of multi-electrode array screening for anticonvulsants in acute rat brain slices. J Neurosci Methods (2009) 0.96
A randomised controlled trial of a community-based healthy lifestyle program for overweight and obese adolescents: the Loozit study protocol. BMC Public Health (2009) 0.96
Dieting and food craving. A descriptive, quasi-prospective study. Appetite (2012) 0.94
Electronic therapeutic contact for adolescent weight management: the Loozit study. Telemed J E Health (2010) 0.94
Flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects. Proc Nutr Soc (2012) 0.94
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci (2014) 0.93
Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor. PLoS One (2013) 0.92
Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum. Mol Pharmacol (2010) 0.92
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. Epilepsia (2010) 0.91
Mechanism of GABA receptor-mediated inhibition of spontaneous GABA release onto cerebellar Purkinje cells. Eur J Neurosci (2004) 0.89
Cognitive change in obese adolescents losing weight. Obes Res (2004) 0.89
Effects of neuropathy on high-voltage-activated Ca(2+) current in sensory neurones. Cell Calcium (2009) 0.88
Evidence that GABA rho subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cells. J Physiol (2006) 0.87
Nerve Terminal GABAA Receptors Activate Ca2+/Calmodulin-dependent Signaling to Inhibit Voltage-gated Ca2+ Influx and Glutamate Release. J Biol Chem (2009) 0.87
Blueberry supplementation induces spatial memory improvements and region-specific regulation of hippocampal BDNF mRNA expression in young rats. Psychopharmacology (Berl) (2012) 0.87
Food cravings and aversions during pregnancy: relationships with nausea and vomiting. Appetite (2002) 0.85
A cost-effective high-throughput digital system for observation and acquisition of animal behavioral data. Behav Res Methods (2009) 0.84
The effectiveness of a Web-based personalized feedback and social norms alcohol intervention on United Kingdom university students: randomized controlled trial. J Med Internet Res (2013) 0.84
Does a high-protein diet improve weight loss in overweight and obese children? Obesity (Silver Spring) (2007) 0.83
Short-term outcomes of community-based adolescent weight management: The Loozit® Study. BMC Pediatr (2011) 0.82
RCT of a high-protein diet on hunger motivation and weight-loss in obese children: an extension and replication. Obesity (Silver Spring) (2009) 0.81
Magazine adverts for healthy and less healthy foods: effects on recall but not hunger or food choice by pre-adolescent children. Appetite (2008) 0.81
Analysis of neural potential of human umbilical cord blood-derived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli. J Neurosci Res (2008) 0.81
Endocannabinoid receptor antagonists: potential for obesity treatment. Treat Endocrinol (2004) 0.81
Guided self-help for disordered eating: A randomised control trial. Behav Res Ther (2010) 0.80
Endogenous cholinergic tone modulates spontaneous network level neuronal activity in primary cortical cultures grown on multi-electrode arrays. BMC Neurosci (2013) 0.79
Inhibition of synaptic transmission and G protein modulation by synthetic CaV2.2 Ca²+ channel peptides. J Physiol (2011) 0.79
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia. J Neurochem (2013) 0.79
Effects and mechanisms of ginseng and ginsenosides on cognition. Nutr Rev (2014) 0.79
A low-Δ9 tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behav Pharmacol (2010) 0.78
Using a runway paradigm to assess the relative strength of rats' motivations for enrichment objects. Behav Res Methods (2010) 0.78
Revealing ensemble state transition patterns in multi-electrode neuronal recordings using hidden Markov models. IEEE Trans Neural Syst Rehabil Eng (2011) 0.78
Multiscale evolving complex network model of functional connectivity in neuronal cultures. IEEE Trans Biomed Eng (2011) 0.78
Co-occurrence of self-reported disordered eating and self-harm in UK university students. Br J Clin Psychol (2009) 0.77
Non-Δ⁹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats. Behav Pharmacol (2012) 0.77
Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses. Eur J Neurosci (2014) 0.77
The effect of flavanol-rich cocoa on cerebral perfusion in healthy older adults during conscious resting state: a placebo controlled, crossover, acute trial. Psychopharmacology (Berl) (2015) 0.76
Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. Phytother Res (2011) 0.76
Phenolic acid intake, delivered via moderate champagne wine consumption, improves spatial working memory via the modulation of hippocampal and cortical protein expression/activation. Antioxid Redox Signal (2013) 0.76
The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signalling. J Physiol (2013) 0.76
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats. Psychopharmacology (Berl) (2010) 0.76
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Epilepsy Res (2013) 0.76
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology (Berl) (2012) 0.76
Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies. Nutr Res Rev (2010) 0.76
Phorbol ester modulation of Ca2+ channels mediates nociceptive transmission in dorsal horn neurones. Pharmaceuticals (Basel) (2013) 0.75
Anticholinesterase-induced epileptiform activity in immature rat piriform cortex slices, in vitro. Neurosci Lett (2010) 0.75
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. PeerJ (2013) 0.75
Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies. Obstet Gynecol (2014) 0.75
Understanding the 'guide' in guided self-help for disordered eating: a qualitative process study. Psychol Psychother (2011) 0.75
Cholinergic modulation of intrinsic fibre-evoked excitatory transmission contains a nicotinic component in immature but not adult rat piriform cortex, in vitro. Neurosci Lett (2007) 0.75